Stifel Downgrades Apollo Endosurgery to Hold, Announces $10 Price Target

Outlook "We continue to deliver best-in-class top-line and bottom-line growth consistent with the long-term guidance provided earlier this year," added Mitchell.  "We are narrowing the range of our